115 related articles for article (PubMed ID: 16293337)
1. Treating patients with HCV genotype 1 and low viraemia: more than meets the eye.
Craxì A; Cammà C
J Hepatol; 2006 Jan; 44(1):4-7. PubMed ID: 16293337
[No Abstract] [Full Text] [Related]
2. Twenty-four hour kinetics of hepatitis C virus and antiviral effect of alpha-interferon.
Boulestin A; Kamar N; Sandres-Sauné K; Legrand-Abravanel F; Alric L; Vinel JP; Rostaing L; Izopet J
J Med Virol; 2006 Mar; 78(3):365-71. PubMed ID: 16419107
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C: changing genotype distribution with important implications for patient management.
van Soest H; Boland GJ; van Erpecum KJ
Neth J Med; 2006 Apr; 64(4):96-9. PubMed ID: 16609154
[TBL] [Abstract][Full Text] [Related]
4. Novel hepatitis C drugs in current trials.
Kronenberger B; Welsch C; Forestier N; Zeuzem S
Clin Liver Dis; 2008 Aug; 12(3):529-55, viii. PubMed ID: 18625427
[TBL] [Abstract][Full Text] [Related]
5. Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment.
Urbani S; Amadei B; Tola D; Pedrazzi G; Sacchelli L; Cavallo MC; Orlandini A; Missale G; Ferrari C
J Hepatol; 2008 Apr; 48(4):548-58. PubMed ID: 18280607
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.
Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Watahiki S; Sato J; Kobayashi M; Arase Y; Ikeda K; Kumada H
J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715
[TBL] [Abstract][Full Text] [Related]
7. Genotype III - HCV infection.
Amarapurkar DN; Choksi M
Trop Gastroenterol; 2007; 28(2):58-63. PubMed ID: 18050840
[No Abstract] [Full Text] [Related]
8. HCV genotype 5: epidemiology and spread of an uncommon genotype.
Verbeeck J; Peigue-Lafeuille H; Ross RS; Abergel A; Nevens F; Van der Merwe S; Van Ranst M; Henquell C
J Clin Virol; 2008 Feb; 41(2):170-1. PubMed ID: 18069057
[No Abstract] [Full Text] [Related]
9. [Genotyping and RNA quantification of hepatitis C virus. ].
Myrmel H; Kursetgjerde T
Tidsskr Nor Laegeforen; 2003 Sep; 123(17):2448. PubMed ID: 14508531
[TBL] [Abstract][Full Text] [Related]
10. Preliminary data for genotype distribution and epidemiological aspects of hepatitis C virus infection in blood donors from Yucatan, Mexico.
García-Montalvo BM; Macossay-Castillo M
Transfus Med; 2007 Dec; 17(6):488-90. PubMed ID: 18067653
[No Abstract] [Full Text] [Related]
11. Hepatitis C virus genotype, hepatitis C virus RNA titers, and response to interferon.
Taliani G; Badolato MC; Pasquazzi C
Ann Intern Med; 1997 Jul; 127(1):89. PubMed ID: 9214263
[No Abstract] [Full Text] [Related]
12. Hepatitis C virus genetic variability in patients undergoing antiviral therapy.
Cristina J; del Pilar Moreno M; Moratorio G
Virus Res; 2007 Aug; 127(2):185-94. PubMed ID: 17449128
[TBL] [Abstract][Full Text] [Related]
13. Oligonucleotide-based therapeutic options against hepatitis C virus infection.
Antivir Ther; ; . PubMed ID: 16759043
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]